trending Market Intelligence /marketintelligence/en/news-insights/trending/pwvj02yhl7ez78iufxrfba2 content esgSubNav
In This List

Onconova Therapeutics receives Nasdaq noncompliance notice

Blog

Insight Weekly: US bank stress tests; cracks in housing market; summer energy supply risks

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches


Onconova Therapeutics receives Nasdaq noncompliance notice

Onconova Therapeutics Inc. said it was no longer in compliance with Nasdaq's minimum closing bid listing requirement of $1 per share.

The Newtown, Pa.-based company has until Nov. 5 to regain compliance by attaining the closing bid price of at least $1 per share for a minimum of 10 consecutive business days.

Onconova said it intends to monitor its closing bid price and was considering options to resolve the noncompliance issue.